AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Oncology Today with Dr Neil Love
00:00
Managing Suboptimal Triplet Responses
Panel recommends trials, close monitoring, and considering triplet strategies or radioligand therapy for poor responders.
Play episode from 55:43
Transcript
